Summary.-Cyclosporin A (Cy A), a novel immunosuppressive agent with apparently selective inhibitory effects on T lymphocytes and little myelotoxicity, was tested for its effects on a variety of syngeneic animal tumours including sarcomas, carcinomas and a T-cell lymphoma. Cy A, given orally or parenterally in repeated doses, had no effect on the growth rates of any of the tumours tested, but a highly significant effect on metastasis was seen in many cases. All the sarcomas examined in both rats and mice, and also the lymphoma, showed a marked increase in their metastases, in some cases even when administration of Cy A was delayed until after excision of the "primary" tumour implants. In contrast no effect of Cy A on metastasis was observed in animals bearing poorly immunogenic mammary or squamous-cell carcinomas. The metastases developing in Cy A-treated animals, when transplanted into normal syngeneic animals, showed no evidence of enhanced metastatic potential compared with their"parent" tumours.
CYCLOSPORIN A (Cy A) is a fungal metabolite the immunosuppressive properties of which have been described by Borel et al. (1978) and include inhibition of humoral immunity (assayed by plaqueforming cell number and haemagglutination titre) and cell-mediated immunity (assayed by skin-graft rejection, graft-vshost disease and experimental allergic encephalitis). It was shown to be effective after oral or parenteral administration, and to inhibit both primary and secondary immune responses. Its mode of action is still imperfectly understood, but in contrast to other immunosuppressive or cytostatic drugs it has little effect on haemopoietic tissues and seems preferentially to inhibit T lymphocytes at an early stage of mitogenic triggering (Borel et al., 1978) . Further advantages are that its effects seem to be reversed fairly rapidly, at least in some systems (Denham et al., 1980) and do not seriously compromise immunity to common pathogens.
Previous work from this laboratory had shown that when animals were putatively immunosuppressed by thymectomy, whole-body X-irradiation or chronic lymph depletion, the incidence of metastases from immunogenic tumours was greatly increased and approached that of poorly immunogenic tumours (Eccles & Alexander, 1974 , 1975 . Although these effects could be reversed by reconstitution of the animals with lymphoid cells before tumour implantation (Eccles, 1978) the possibility that surgical stress or radiation damage had contributed to the increased incidence of metastases could not be discounted entirely. Subsequently, it was shown that similar tumours grown in congenitally athymic "nude" rats also exhibited enhanced metastasis over immunecompetent hosts (Eccles et al., 1979; Eccles, 1980) although the athymic rats were of mixed genetic background, and not syngeneic with the Lister Hooded/ Cbi tumours under investigation. Cyclosporin A offered the possibility of studying the growth and metastasis ofa wide variety of rat and mouse tumours in strictly syngeneic hosts, subjected to specific immune suppression not requiring surgery, the use of antibiotics or filterbox housing as had all previous experimental systems used. In addition, the rapidity with which Cy A exerts its effects, from which animals recover after cessation of treatment, allowed a more detailed examination of the results of suppression of host Tdependent immune responses at various stages of tumour growth and after primary-tumour excision.
MATERIALS AND METHODS
Rat tumours.-Highly inbred male Lister Hooded/Cbi rats were used between 10 and 12 weeks of age. The tumours studied were induced in this colony of animals, all (except HSN) within the last 3-years. MC24 and MC26 fibrosarcomas were induced by methylcholanthrene, and HSN sarcoma by benzo(a)-pyrene.
Mouse tumours.-Male, and/or female mice of inbred strains C57BL/Cbi, DBA/2 and CBA/Ca were used between 10 and 12 weeks of age. The tumours studied were as follows:
FS6 and FS29; benzpyrene-induced fibrosarcomas syngeneic with male and femnale C57BL/Cbi mice respectively. DM1, DM2 and DM6; squamous-cell carcinomas induced in C57BL/Cbi mice by skin-painting with DMBA (dimethylbenzanthracene) in 1979. MT1, MT3 and MT5; mammary adenocarcinomas arising in 1979 as a result of natural transmission of Bittner factor (mammary-tumour virus) in female CBA/Ca mice, transplanted in syngeneic virus-free female mice.
L5178YE; a methylcholanthrene-induced T-cell lymphoma of female DBA/2 mice, introduced into our Institute in 1961.
Tumours were only studied in their first 10 in vivo transplant generations, before fresh stocks were obtained from liquid N2, and unless specified otherwise they were grown from mechanically prepared cell suspensions, and not subjected to proteolytic enzymes or in vitro culture.
Cyclosporin A (Cy A). growth, the same number of controls receiving an equivalent volume (0-02 ml) of olive oil. Groups of 8 rats -which seem to be more sensitive to Cy Areceived daily doses of 20 mg/kg on Days 3-10 of tumour growth or on Days 3-10 after excision, whilst further groups of 8 controls received olive oil.
(c) The effects of i.m. Cy A and variation in the time of its administration were studied using rat sarcoma MC24. Cy A was inoculated i.m. into the non-tumour-bearing thighs of groups of 8 rats at a dose of 40 mg/kg on 3 alternate days as follows: before tumour implantation, at various times during tumour growth, and after tumour resection. Similar experiments were performed using single inoculations of 80 mg/kg Cy A. Fig. 1 shows the growth rates of mouse sarcoma FS6 and rat sarcoma MC24 in control and Cy A-treated animals. It can be seen that daily doses of 20 or 80 mg/kg of this agent had no significant effect on either tumour; similar results were obtained with the other tumours tested. Also, tumours grown i.m. for metastasis studies were regularly dissected and weighed after excision; those from Cy Atreated and control animals were found to be of comparable mass, even when counted numbers of tumour cells were Although the number of animals in the groups was small, it is clear that even a single injection of Cy A, whether early or late during tumour development or up to 3-4 weeks after tumour excision, induced a significant increase in metastases. It is possible that the inoculation of Cy A in oil gives rise to a "depot effect", so that the drug is available for some time after its administration. However, the reduced effectiveness when the drug was administered 3 days before the implant, and the lack of effect when given on Day -7, indicate that it probably persists systemically little longer than 3 days. It has been shown also that animals receiving continuous daily doses of Cy A recovered rapidly from the effects once treatment was terminated (Denham et al., 1980 (1) Doses similar to those used in this study have been shown to permit the L survival of skin allografts in our rat LN LN colony (Denham et al., 1980) . (2) Production of specific antibody to tumour antigens estimated by a direct binding assay was totally inhibited, as l,N+L described previously in athymic animals L (Eccles et al., 1979) . This effect is also found in athymic or LN + L thymectomized/irradiated hosts (Eccles et al., 1979; Eccles & Alexander, 1976 Eccles, 1978) . Treatment with high i.m. doses of Cy A after excision of primary sarcoma implants also induced metastases in a high proportion of animals, by allowing outgrowth of cells that had alreadv disseminated at the time of treatment and which would normally have been controlled by the host. These data are consistent with the idea that even "nonmetastatic" sarcomas release cells which colonize secondary sites and retain their ability to proliferate (Eccles & Alexander, 1975) .
RESULTS

Growth rates of tumours
Similar results were obtained with the immunogenic L5178YE lymphoma which rarely yields metastases in normal animals but which disseminated readily in Cy Atreated mice. Although this drug is thought to inhibit T-cell proliferation (White et al., 1979a) , and has been shown to interfere with the in vitro growth of a T-cell like lymphoma, but not a B-cell like lymphoma (White et al., 1979b) , no significant effects were seen on the growth of the T-cell lymphoma L5178YE in vivo. It is possible that the drug did not reach the tumour cells at concentrations adequate to exert cytostatic effects, but the systemic effects on the host were sufficient to allow the tumour to escape from immunological control.
The metastatic potential of induced and "dormant" metastases was of interest, since it has been suggested that metastases develop from subpopulations of cells of unique metastasizing ability, preexisting within primary tumours (Poste & Fidler, 1 980 (Davey et al., 1979) . Thus it is suggested thlat, for anaplastic tuimoturs in which the population is inherently highly clonogenic (i.e. capable of growing from very low inocula in vivo) the ultimate survival of disseminated cells is determined mainly by the degree of host immutnity they invoke.
The failure of Cy A to affect the metastasis of all 6 carcinomas tested is in direct contrast to these resuilts. It is not surprising that an immunosuippressive agent should only potentiate metastases of immunogenic tumoturs, but what is of interest is thfat the carcinom-as stuidied, unlike poorly immunogenic sarcomias and lvmphomas (Eccles & Alexander, 1974; Dlavey et al., 1979) , had very low rates of spontaneous metastasis, and clearly their failure to disseminate successfully was not duie to T-cell-dependent host immtune responses.
All the carcinomas in early transplanit generations were moderately or well differentiated and it is possible that a significant component of the population undergoes maturation, with concomiitant loss of proliferative capacity. This is suggested also by the fact that they are, as a whole, much less clonogenic in vivo than the sarcomas and lymphomas; high cell numbers being required for growth (even when injected i.v.) regardless of host 2r-, (s immune status (Tarin & Price, 1979) . Inverse correlations between the degree of differentiation of animal tumours and their metastatic capacity have been reported (Belnap et al., 1979; Sordat et al., 1977) and we noticed also that with successive in vivo passages certain tumours became less well differentiated and this was always associated with a decrease in TD50 values and increased incidence of spontaneous metastasis (unpublished observations). Thus anaplastic non-immunogenic carcinomas can behave similarly to their counterparts of mesodermal origin.
These apparent correlations invite speculation, but more work is required to determine the actual proliferative capacity, growth fraction and other kinetic parameters of tumour-cell populations of different histological appearance in order to explore these interesting possibilities. It has been shown that maturation promotors (e.g. dimethylformamide) can induce tumour cells to develop a more differentiated phenotype in vitro with resulting loss of tumorigenicity in vivo (Calabresi et al., 1979) and experiments are in progress to determine whether similar compounds might operate in vivo to reduce tumour growth and metastasis.
In summary, the use of Cy A as an immunosuppressant with few side effects has allowed a survey of the role of T-celldependent immune responses in the control of metastases in a variety of systems. It is evident that with some tumours which are demonstrably immunogenic (as in the sarcomas and lymphomas described) T-cell function is required not only for the initiation of an immune response, but also for its maintenance, even after "primary" tumour resection. For tumours of negligible immunogenicity (e.g. the mammary and squamous-cell carcinomas) inhibition of T-cell function had no effect on metastases, and in these cases factors other than host immunity must be preventing successful dissemination.
